Description

Mycophenolate Dimer is a high-purity chemical intermediate of significant importance in advanced pharmaceutical synthesis. This compound is primarily valued for its role in the development and production of immunosuppressive agents and other active pharmaceutical ingredients (APIs). It is a critical material for pharmaceutical R&D laboratories and contract manufacturing organizations (CMOs) engaged in the synthesis of complex therapeutic molecules. Our supply ensures consistent quality and reliable availability for critical global supply chains.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of mycophenolate mofetil and related immunosuppressant drugs.
• Active Pharmaceutical Ingredient (API) Development: Used in research and process development for new immunosuppressive therapies.
• Reference Standard: Serves as a high-purity standard for analytical method development and quality control in pharmaceutical laboratories.
• Biochemical Research: Utilized in studies investigating the mechanism of action of inosine monophosphate dehydrogenase (IMPDH) inhibitors.
• Process Chemistry: Employed in scaling up and optimizing manufacturing routes for final drug substances.
• Custom Synthesis: A starting material for the preparation of novel ester and salt derivatives for pharmacological evaluation.

Basic Information

Product Name	Mycophenolate Dimer
CAS No.	165684-44-6
Molecular Formula	C46H54O14
Molecular Weight	854.92 g/mol
Synonyms	Mycophenolate Dimer; Mycophenolic Acid Dimer; (4E)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methylhex-4-enoic Acid Dimer; 2-Morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate Dimer; Mycophenolate Mofetil Related Compound; Mycophenolic Acid 2-Morpholinoethyl Ester Dimer
EINECS	Contact for details

Quality Control

Our Mycophenolate Dimer is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation (IR, NMR), to ensure it meets the stringent requirements for pharmaceutical intermediates. We provide full traceability and detailed Certificates of Analysis (COA) with every shipment, confirming compliance with agreed specifications. Our quality commitment supports applications requiring GMP-grade materials.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept in a dry environment. For long-term storage, consider desiccant or inert atmosphere conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.